| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/MP.2016.44 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/mp.2016.44 |
| P698 | PubMed publication ID | 27067014 |
| P50 | author | Song-hua Fan | Q85510266 |
| Julio Licinio | Q15429111 | ||
| P2093 | author name string | Y Yang | |
| W Li | |||
| D Yang | |||
| L Zeng | |||
| X Du | |||
| X Zhang | |||
| X Xu | |||
| M Liu | |||
| J Chen | |||
| Z Fang | |||
| H Wei | |||
| C Zhou | |||
| H Meng | |||
| P Zheng | |||
| B Zeng | |||
| N D Melgiri | |||
| P Xie | |||
| P2860 | cites work | 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder. | Q50663896 |
| Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. | Q51853484 | ||
| A structured interview version of the Hamilton Depression Rating Scale: evidence of reliability and versatility of administration. | Q52864890 | ||
| Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests | Q22673963 | ||
| Data, information, knowledge and principle: back to metabolism in KEGG | Q24568332 | ||
| Metagenomic microbial community profiling using unique clade-specific marker genes | Q24599864 | ||
| Human gut microbiome viewed across age and geography | Q24602950 | ||
| The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants | Q24609857 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 | ||
| Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity | Q27329095 | ||
| Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
| Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 | ||
| Enhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors | Q28579694 | ||
| Trimmomatic: a flexible trimmer for Illumina sequence data | Q29547278 | ||
| UniFrac: a new phylogenetic method for comparing microbial communities | Q29547435 | ||
| Prodigal: prokaryotic gene recognition and translation initiation site identification | Q29547611 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
| PyNAST: a flexible tool for aligning sequences to a template alignment | Q29616628 | ||
| Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve | Q29616854 | ||
| Normal gut microbiota modulates brain development and behavior | Q29616855 | ||
| Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders | Q29617111 | ||
| Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour | Q29617115 | ||
| The impact of the gut microbiota on human health: an integrative view | Q29617446 | ||
| The GABAergic deficit hypothesis of major depressive disorder. | Q30464954 | ||
| Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients | Q30468799 | ||
| Maternal and offspring pools of osteocalcin influence brain development and functions | Q30559531 | ||
| Ribosomal Database Project: data and tools for high throughput rRNA analysis | Q30703827 | ||
| Taxonomic database and cut-off value for processing mcrA gene 454 pyrosequencing data by MOTHUR. | Q30826550 | ||
| Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria | Q33398928 | ||
| Analysis of 16S rRNA amplicon sequencing options on the Roche/454 next-generation titanium sequencing platform | Q34038133 | ||
| The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice | Q34193512 | ||
| IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth | Q34229322 | ||
| The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner | Q34300369 | ||
| Gut-brain axis: how the microbiome influences anxiety and depression | Q34326411 | ||
| Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse | Q34441243 | ||
| Altered fecal microbiota composition in patients with major depressive disorder. | Q34472196 | ||
| Altered colonic function and microbiota profile in a mouse model of chronic depression. | Q34775070 | ||
| Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma | Q35098539 | ||
| Correlation between the human fecal microbiota and depression. | Q35179996 | ||
| Social and economic burden of mood disorders | Q35189625 | ||
| Conducting a microbiome study | Q35208886 | ||
| Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression | Q35613219 | ||
| Comorbid anxiety and depression. | Q36334832 | ||
| Host remodeling of the gut microbiome and metabolic changes during pregnancy | Q36421887 | ||
| Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice. | Q36485097 | ||
| Utilities for quantifying separation in PCA/PLS-DA scores plots | Q36501475 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression | Q36800963 | ||
| Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition | Q36932860 | ||
| The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? | Q37775892 | ||
| Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach | Q38985361 | ||
| Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice. | Q39897386 | ||
| Microbiota is essential for social development in the mouse | Q42733803 | ||
| Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression | Q42942477 | ||
| Fecal microbiota transfer may increase irritable bowel syndrome and inflammatory bowel diseases-associated bacteria | Q43548253 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Bacterial infection causes stress-induced memory dysfunction in mice | Q45242714 | ||
| Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies | Q46324032 | ||
| The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. | Q46612209 | ||
| Amino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depression | Q48287388 | ||
| Plasma amino acid levels discriminate between control subjects and mildly depressed elderly women. | Q48631302 | ||
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression. | Q48833582 | ||
| Fronto-cingulate effective connectivity in major depression: a study with fMRI and dynamic causal modeling. | Q48943739 | ||
| Reduced anxiety-like behavior and central neurochemical change in germ-free mice. | Q50659254 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | 786-796 | |
| P577 | publication date | 2016-04-12 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | |
| P478 | volume | 21 |
| Q55110638 | "Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders. |
| Q47567555 | A Return to Wisdom: Using Sickness Behaviors to Integrate Ecological and Translational Research |
| Q96230071 | A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration |
| Q58800559 | A metagenomic study of the gut microbiome in Behcet's disease |
| Q46460124 | A new pathway for the gut microbiota to modulate the brain: activation of pattern-recognition receptors by microbial products |
| Q93077579 | A potential role for the gut microbiome in substance use disorders |
| Q38643160 | A psychology of the human brain-gut-microbiome axis |
| Q90149313 | Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress |
| Q64085536 | Age-Associated Changes in the Immune System and Blood⁻Brain Barrier Functions |
| Q89628910 | Age-specific differential changes on gut microbiota composition in patients with major depressive disorder |
| Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder |
| Q99404602 | Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function |
| Q92685749 | Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis |
| Q91828379 | Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice |
| Q37345533 | Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine |
| Q93336850 | Altered fecal microbiota composition in the Flinders sensitive line rat model of depression |
| Q61443153 | Altered gut metabolome contributes to depression-like behaviors in rats exposed to chronic unpredictable mild stress |
| Q98613427 | Altered gut microbiota associated with symptom severity in schizophrenia |
| Q57138823 | American Gut: an Open Platform for Citizen Science Microbiome Research |
| Q52641621 | An Ontology Systems Approach on Human Brain Expression and Metaproteomics. |
| Q57468220 | An insight into gut microbiota and its functionalities |
| Q92783333 | An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder |
| Q92929992 | Analysis of microbiota in elderly patients with Acute Cerebral Infarction |
| Q38620528 | Animal inflammation-based models of depression and their application to drug discovery. |
| Q97518331 | Antibiotic-Driven Gut Microbiome Disorder Alters the Effects of Sinomenine on Morphine-Dependent Zebrafish |
| Q58586863 | Antidepressant Effects of Rosemary Extracts Associate With Anti-inflammatory Effect and Rebalance of Gut Microbiota |
| Q58728120 | Antidepressant-Like Effects of Extract on Chronic Unpredictable Stress Rats Through Restoration of Gut Microbiota Homeostasis |
| Q64065500 | Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior |
| Q89493771 | Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential |
| Q33852050 | Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders |
| Q90128977 | Are we Ready for a "Microbiome-Guided Behaviour" Approach? |
| Q60949291 | Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer's Disease using 16S rRNA gene and metagenomic sequencing analysis |
| Q100693775 | Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice |
| Q89938769 | Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease |
| Q48001597 | Biochemical effects of venlafaxine on astrocytes as revealed by 1H NMR-based metabolic profiling |
| Q59124327 | Biodiversity, the Human Microbiome and Mental Health: Moving toward a New Clinical Ecology for the 21st Century? |
| Q91819820 | Biological underpinnings from psychosocial stress towards appetite and obesity during youth: research implications towards metagenomics, epigenomics and metabolomics |
| Q34557243 | Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis |
| Q104795022 | CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice |
| Q91235824 | Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice |
| Q90371599 | Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder |
| Q91632696 | Commensal Microbiota Regulation of Metabolic Networks During Olfactory Dysfunction in Mice |
| Q42370501 | Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research |
| Q46259903 | Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model. |
| Q46251992 | Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders |
| Q41665354 | Cross Talk: The Microbiota and Neurodevelopmental Disorders |
| Q55067205 | Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis. |
| Q96305115 | Crosstalk between the microbiota-gut-brain axis and depression |
| Q91557441 | Curculigoside facilitates fear extinction and prevents depression-like behaviors in a mouse learned helplessness model through increasing hippocampal BDNF |
| Q64228734 | Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies |
| Q52596479 | Current understanding of the human microbiome. |
| Q49912400 | Depression and obesity: evidence of shared biological mechanisms. |
| Q92978949 | Depression phenotype identified by using single nucleotide exact amplicon sequence variants of the human gut microbiome |
| Q89507956 | Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study |
| Q64118633 | Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health |
| Q92155618 | Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases |
| Q91883877 | Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects |
| Q92940447 | Differences in gut microbiota composition of laying hen lines divergently selected on feather pecking |
| Q57098990 | Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function |
| Q92059662 | Diterpene Ginkgolides Exert an Antidepressant Effect Through the NT3-TrkA and Ras-MAPK Pathways |
| Q41606180 | Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine |
| Q55000093 | Dysbiotic drift and biopsychosocial medicine: how the microbiome links personal, public and planetary health. |
| Q89747866 | Early-life microbiota transplantation affects behavioural responses, serotonin and immune characteristics in chicken lines divergently selected on feather pecking |
| Q51143827 | Ecological Restoration of Antibiotic-Disturbed Gastrointestinal Microbiota in Foregut and Hindgut of Cows. |
| Q92022524 | Effects of regulating gut microbiota on the serotonin metabolism in the chronic unpredictable mild stress rat model |
| Q37398383 | Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies |
| Q95936660 | Ergothioneine, a metabolite of the gut bacterium Lactobacillus reuteri, protects against stress-induced sleep disturbances |
| Q40242658 | Ethical Issues in Fecal Microbiota Transplantation in Practice |
| Q37589158 | Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. |
| Q97519611 | Extracellular Matrix and Oxidative Phosphorylation: Important Role in the Regulation of Hypothalamic Function by Gut Microbiota |
| Q60910510 | Faecal Short Chain Fatty Acids Profile is Changed in Polish Depressive Women |
| Q61943463 | Fecal Microbiota Analysis in Patients Going through a Depressive Episode during Treatment in a Psychiatric Hospital Setting |
| Q39004831 | Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry |
| Q90532635 | Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice |
| Q36932850 | From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways |
| Q64250176 | Genetic risk factors for eating disorders: an update and insights into pathophysiology |
| Q55714791 | Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex. |
| Q93018171 | Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study |
| Q64055380 | Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis |
| Q91794756 | Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression |
| Q92106368 | Gut Microbiome and Modulation of CNS Function |
| Q92408237 | Gut Microbiota Changes in Patients with Bipolar Depression |
| Q92237631 | Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China |
| Q60947161 | Gut Microbiota Features in Young Children With Autism Spectrum Disorders |
| Q91839610 | Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway |
| Q57111788 | Gut Microbiota and Relevant Metabolites Analysis in Alcohol Dependent Mice |
| Q47832545 | Gut Microbiota and the Neuroendocrine System |
| Q89683324 | Gut Microbiota is the Key to the Antidepressant Effect of Chaihu-Shu-Gan-San |
| Q90052185 | Gut hormones in microbiota-gut-brain cross-talk |
| Q92332225 | Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health |
| Q99212120 | Gut microbial clues to bipolar disorder: State-of-the-art review of current findings and future directions |
| Q100694558 | Gut microbial molecules in behavioural and neurodegenerative conditions |
| Q36175916 | Gut microbiome and major depressive disorder : The other side of ourselves |
| Q57176780 | Gut microbiota associations with common diseases and prescription medications in a population-based cohort |
| Q37618646 | Gut microbiota dysbiosis contributes to the development of hypertension. |
| Q92788040 | Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2 |
| Q90596633 | Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice |
| Q90317731 | Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model |
| Q58759636 | Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus |
| Q89429091 | Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities |
| Q64869644 | Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. |
| Q46395958 | Gut-Brain Axis and Behavior |
| Q57113261 | Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis |
| Q48372436 | Gut-brain axis in 2016: Brain-gut-microbiota axis - mood, metabolism and behaviour |
| Q47610464 | Gutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling. |
| Q92495254 | Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder |
| Q55019020 | Gut–Brain Axis and Mood Disorder. |
| Q54969645 | Help, hope and hype: ethical considerations of human microbiome research and applications. |
| Q89784349 | Host-microbiome coevolution can promote cooperation in a rock-paper-scissors dynamics |
| Q55265154 | Huddling remodels gut microbiota to reduce energy requirements in a small mammal species during cold exposure. |
| Q37648213 | Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics |
| Q92040409 | Immune mechanisms of stress susceptibility and resilience: Lessons from animal models |
| Q91845019 | Immunity, microbiota and kidney disease |
| Q46246072 | Impact of Omega-3 Fatty Acids on the Gut Microbiota. |
| Q52311705 | Indole, a Signaling Molecule Produced by the Gut Microbiota, Negatively Impacts Emotional Behaviors in Rats. |
| Q38631794 | Infant Gut Microbiome Associated With Cognitive Development. |
| Q58548853 | Infantile Colic: New Insights into an Old Problem |
| Q36932860 | Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition |
| Q91521259 | Inflammatory Bowel Disease: A Stressed "Gut/Feeling" |
| Q47745353 | Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities |
| Q40058836 | Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry. |
| Q41548141 | Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine. |
| Q58780873 | Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression |
| Q64061225 | Integrated Metabolomics and Proteomics Analysis Revealed Second Messenger System Disturbance in Hippocampus of Chronic Social Defeat Stress Rat |
| Q100533641 | Integrated phosphoproteomic and metabolomic profiling reveals perturbed pathways in the hippocampus of gut microbiota dysbiosis mice |
| Q39090621 | Interactions between the microbiota, immune and nervous systems in health and disease. |
| Q47773748 | Intestinal microbiome-gut-brain axis and irritable bowel syndrome. |
| Q58765673 | Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants |
| Q91783414 | Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease |
| Q92814756 | Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise-Searching for Gap Fillers in the Oxidative Stress Way of Thinking |
| Q91253098 | Is adolescence the missing developmental link in Microbiome-Gut-Brain axis communication? |
| Q61805758 | Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain |
| Q89202860 | Linking the Gut Microbiota to a Brain Neurotransmitter |
| Q57512985 | Making Sense of … the Microbiome in Psychiatry |
| Q104737953 | Mechanisms of microbial-neuronal interactions in pain and nociception |
| Q58580848 | Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder |
| Q47642189 | Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers |
| Q55002056 | Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex. |
| Q91895152 | Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone |
| Q64076445 | Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques |
| Q90813920 | Metagenome-wide association of gut microbiome features for schizophrenia |
| Q64098548 | Mice lacking Casp1, Ifngr and Nos2 genes exhibit altered depressive- and anxiety-like behaviour, and gut microbiome composition |
| Q96124228 | Microbes and mental health: Can the microbiome help explain clinical heterogeneity in psychiatry? |
| Q41520884 | Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. |
| Q97643856 | Microbial regulation of organismal energy homeostasis |
| Q90232431 | Microbiome Influence in the Pathogenesis of Prion and Alzheimer's Diseases |
| Q39388187 | Microbiome: A Potential Component in the Origin of Mental Disorders. |
| Q47207303 | Microbiota Modulate Anxiety-Like Behavior and Endocrine Abnormalities in Hypothalamic-Pituitary-Adrenal Axis |
| Q37116628 | Microbiota Modulates Behavior and Protein Kinase C mediated cAMP response element-binding protein Signaling |
| Q30253023 | Microbiota alteration is associated with the development of stress-induced despair behavior |
| Q93145936 | Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health Status |
| Q58606725 | Mood-Related Central and Peripheral Clocks |
| Q89684509 | Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression |
| Q90520292 | Neuroinflammation, Gut-Brain Axis and Depression |
| Q58760977 | Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling |
| Q89106921 | Neurotransmitter modulation by the gut microbiota |
| Q47614920 | Nutritional psychiatry: the present state of the evidence |
| Q36320795 | Opportunistic Sampling of Roadkill as an Entry Point to Accessing Natural Products Assembled by Bacteria Associated with Non-anthropoidal Mammalian Microbiomes. |
| Q59128134 | Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis |
| Q50177789 | Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. |
| Q94560655 | Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis |
| Q98200229 | Perinatal Depression: Heterogeneity of Disease and in Animal Models |
| Q89964006 | Peripheral Routes to Neurodegeneration: Passing Through the Blood-Brain Barrier |
| Q90320125 | Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome |
| Q60309361 | Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder |
| Q46237980 | Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. |
| Q96303322 | Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification |
| Q89741613 | Precision medicine in perinatal depression in light of the human microbiome |
| Q48452256 | Preface: The Gut Microbiome and Behavior under the microscope: Where to focus? |
| Q33843348 | Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization |
| Q91637380 | Prophylactic Effects of Bifidobacterium adolescentis on Anxiety and Depression-Like Phenotypes After Chronic Stress: A Role of the Gut Microbiota-Inflammation Axis |
| Q97423295 | Proteomics-based screening of the target proteins associated with antidepressant-like effect and mechanism of nimesulide |
| Q92873306 | Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective |
| Q47808638 | Recent developments in understanding the role of the gut microbiota in brain health and disease |
| Q88907581 | Recognizing Depression from the Microbiota⁻Gut⁻Brain Axis |
| Q64950233 | Reduced microbiome alpha diversity in young patients with ADHD. |
| Q64084571 | Relative abundance of Akkermansia spp. and other bacterial phylotypes correlates with anxiety- and depressive-like behavior following social defeat in mice |
| Q90388296 | Reproductive and Behavior Dysfunction Induced by Maternal Androgen Exposure and Obesity Is Likely Not Gut Microbiome-Mediated |
| Q92970043 | Role of Tryptophan in Microbiota-Induced Depressive-Like Behavior: Evidence From Tryptophan Depletion Study |
| Q47623310 | Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly. |
| Q52665670 | Sex differences in gut microbiota in patients with major depressive disorder. |
| Q94663991 | Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats |
| Q57491015 | Short Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild Stress |
| Q91102272 | Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients |
| Q91852678 | Stress-induced disturbances along the gut microbiota-immune-brain axis and implications for mental health: Does sex matter? |
| Q92502651 | Systematic Analysis of Impact of Sampling Regions and Storage Methods on Fecal Gut Microbiome and Metabolome Profiles |
| Q64249465 | Systematic Review of Gut Microbiota and Major Depression |
| Q92539102 | Talking about a microbiome revolution |
| Q57120648 | The Brain-Gut-Microbiome Axis |
| Q36182979 | The Central Nervous System and the Gut Microbiome. |
| Q47310400 | The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists |
| Q90144997 | The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients? |
| Q57186276 | The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications |
| Q93164973 | The Gut-Brain-Axis on the Manifestation of Depressive Symptoms in Epilepsy: An Evidence-Driven Hypothesis |
| Q57817925 | The Gut-Microglia Connection: Implications for Central Nervous System Diseases |
| Q64105189 | The Impact of DNA Extraction Methods on Stool Bacterial and Fungal Microbiota Community Recovery |
| Q39182242 | The Microbiome and Host Behavior. |
| Q64892118 | The Role of Chemokines in the Pathophysiology of Major Depressive Disorder. |
| Q60046493 | The Role of Microbiome in Insomnia, Circadian Disturbance and Depression |
| Q90154043 | The Role of the Gut Microbiota in Dietary Interventions for Depression and Anxiety |
| Q47307050 | The dopamine motive system: implications for drug and food addiction |
| Q64939436 | The effects of antipsychotic medications on microbiome and weight gain in children and adolescents. |
| Q93181443 | The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials |
| Q39100917 | The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies |
| Q61798989 | The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice |
| Q92252661 | The gut microbiome in psychiatry: A primer for clinicians |
| Q94592321 | The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression |
| Q92128620 | The gut microbiome regulates the increases in depressive-type behaviors and in inflammatory processes in the ventral hippocampus of stress vulnerable rats |
| Q37730411 | The gut microbiota and psychiatric illness |
| Q60654220 | The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence |
| Q100946502 | The gut microbiota-brain axis in behaviour and brain disorders |
| Q39154504 | The link between inflammation, bugs, the intestine and the brain in alcohol dependence |
| Q46317552 | The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour. |
| Q93069489 | The microbiome and mental health: Hope or hype? |
| Q90911578 | The microbiota regulate neuronal function and fear extinction learning |
| Q39447424 | The microbiota-gut-brain axis as a key regulator of neural function and the stress response: Implications for human and animal health |
| Q92987643 | The molecular and cellular mechanisms of depression: a focus on reward circuitry |
| Q38607424 | The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder |
| Q63589897 | The neuroactive potential of the human gut microbiota in quality of life and depression |
| Q38828405 | Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation |
| Q64252440 | Therapeutic Potential of the Microbiome in the Treatment of Neuropsychiatric Disorders |
| Q90400950 | There is No Distinctive Gut Microbiota Signature in the Metabolic Syndrome: Contribution of Cardiovascular Disease Risk Factors and Associated Medication |
| Q58586914 | Tiansi Liquid Modulates Gut Microbiota Composition and Tryptophan⁻Kynurenine Metabolism in Rats with Hydrocortisone-Induced Depression |
| Q91652745 | Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice |
| Q55245667 | Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. |
| Q36186527 | Transforming Life: A Broad View of the Developmental Origins of Health and Disease Concept from an Ecological Justice Perspective |
| Q92483739 | Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice |
| Q93217452 | Updated review of research on the gut microbiota and their relation to depression in animals and human beings |
| Q33582649 | Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats |
| Q57155162 | Urinary biomarker panel for diagnosing patients with depression and anxiety disorders |
| Q64262134 | Urinary metabolite signature in bipolar disorder patients during depressive episode |
| Q55233736 | Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. |
| Q47137050 | Visceral Inflammation and Immune Activation Stress the Brain |
| Q57462526 | Vitamin D and the gut microbiome: a systematic review of in vivo studies |
| Q90932695 | What can the gut microbiome teach us about the connections between child physical and mental health? A systematic review |
| Q91723987 | You've got male: Sex and the microbiota-gut-brain axis across the lifespan |
| Q50041500 | [The human intestinal microbiome and why you have to think twice before prescribing antibiotics!] |
Search more.